Stock 6919 CALIWAY BIOPHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Caliway Biopharmaceuticals Co., Ltd.

Equities

6919

TW0006919004

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-07-11 pm EDT 		5-day change 1st Jan Change
681 TWD +0.74% Intraday chart for Caliway Biopharmaceuticals Co., Ltd. -3.95% +256.08%
May. 13 Caliway Biopharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 25 Caliway Biopharmaceuticals Co., Ltd. Announces CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints CI

Shareholders

NameEquities%Valuation
Yufang Ling
11.08 %
15,416,726 11.08 % 294 M NT$
Kuihui Xu
7.865 %
10,941,498 7.865 % 209 M NT$
Gaorong Zhang
1.301 %
1,810,008 1.301 % 35 M NT$
Quancheng Qiu
1.295 %
1,802,006 1.295 % 34 M NT$

Company contact information

Caliway Biopharmaceuticals Co. Ltd.

Xintai 5th Road 32F.-9, No.99, Sec. 1

221 00, New Taipei City

+

http://www.caliway.com.tw
address Caliway Biopharmaceuticals Co., Ltd.(6919)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sector Other Pharmaceuticals

1st Jan change Capi.
CALIWAY BIOPHARMACEUTICALS CO., LTD. Stock Caliway Biopharmaceuticals Co., Ltd.
+256.08% 2.92B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+62.66% 854B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.42% 636B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.37% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.16% 324B
ABBVIE INC. Stock AbbVie Inc.
+9.87% 301B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.66% 247B
ROCHE HOLDING AG Stock Roche Holding AG
+4.21% 230B
NOVARTIS AG Stock Novartis AG
+17.90% 228B
AMGEN INC. Stock Amgen Inc.
+14.86% 177B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 6919 Stock
  4. Company Caliway Biopharmaceuticals Co., Ltd.